Publicações

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

AuthID
P-00P-JH3

Author(s)

Tilly, H

Morschhauser, F

Casasnovas, O

Molina, TJ

Feugier, P

Le Gouill, S

Haioun, C

Tournilhac, O

Bouabdallah, R

Gabarre, J

Lamy, T

Cabecadas, J

Becker, S

Jardin, F

Mounier, N

Salles, G

Group Author(s)

Lymphoma Study Assoc

Tipo de Documento

Article

Year published

2018

Publicado

in LANCET HAEMATOLOGY, ISSN: 2352-3026

Volume: 5, Número: 9, Páginas: E403-E410 (8)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/s2352-3026(18)30131-5

SCOPUS: 2-s2.0-85052473352

Wos: WOS:000443210100011

Source Identifiers

ISSN: 2352-3026

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

Links Úteis

Ajuda